Home Cart Sign in  
Chemical Structure| 596-51-0 Chemical Structure| 596-51-0

Structure of Glycopyrrolate
CAS No.: 596-51-0

Chemical Structure| 596-51-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Glycopyrrolate is a muscarinic competitive antagonist used as an antispasmodic.

Synonyms: Glycopyrronium bromide; Glycopyrrolate bromide; NVA 237

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Glycopyrrolate

CAS No. :596-51-0
Formula : C19H28BrNO3
M.W : 398.33
SMILES Code : C[N+]1(C)CC(OC(C(O)(C2CCCC2)C3=CC=CC=C3)=O)CC1.[Br-]
Synonyms :
Glycopyrronium bromide; Glycopyrrolate bromide; NVA 237
MDL No. :MFCD00072137

Safety of Glycopyrrolate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02634983 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - United Kingdom ... More >> Novartis Investigative Site Sheffield, South Yorkshire, United Kingdom, S10 2JF Novartis Investigative Site Bradford, West Yorkshire, United Kingdom, BD9 6RJ Novartis Investigative Site Manchester, United Kingdom, M23 9QZ Less <<
NCT01511627 Hysterectomy Not Applicable Withdrawn(Research question wa... More >>s answered by Acta Anaesthesiol Scand 2012; 56 102-109.) Less << - Canada, Saskatchewan ... More >> Saskatoon City Hospital Saskatoon, Saskatchewan, Canada, S7K0M7 Less <<
NCT02325648 - Completed - Korea, Republic of ... More >> Severance Hospital Seoul, South Korea, Korea, Republic of, 120-752 Less <<
NCT03735563 Surfactant Deficiency Syndrome... More >> Neonatal Less << Phase 4 Not yet recruiting October 31, 2020 -
NCT01703624 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - United Kingdom ... More >> Medicines Evaluation Unit Manchester, United Kingdom, M23 9QZ Less <<
NCT02446249 Squamous Cell Head and Neck Ca... More >>ncer Radiation Induced Xerostomia Salivary Hypofunction Less << Phase 1 Phase 2 Recruiting November 1, 2022 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL)    800-411-1222 ext TTY8664111010    prpl@mail.cc.nih.gov Less <<
NCT03316963 Snoring Early Phase 1 Recruiting August 2019 United States, Georgia ... More >> Raj C. Dedhia Recruiting Atlanta, Georgia, United States, 30308 Contact: Raj C Dedhia, MD, MS    404-778-3015    raj.dedhia@emory.edu Less <<
NCT02684331 - Recruiting January 2019 Denmark ... More >> The diabetes outpatient clinic, Slagelse Hospital, Denmark Recruiting Slagelse, Denmark, 4200 Contact: Peter H Gaede, DMSc    +45 23959055    phgo@regionsjaelland.dk    Contact: Annemie S Bojer, DM    +45 22857526    asph@regionsjaelland.dk    Principal Investigator: Martin H Soerensen, DM Less <<
NCT01970878 - Completed - -
NCT02622243 Asthma Phase 4 Completed - Canada, Saskatchewan ... More >> Asthma Research Lab Saskatoon, Saskatchewan, Canada, S7N 0W8 Less <<
NCT01970878 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT01422304 Neuromuscular Blockade ... More >> Arthroplasty, Replacement, Hip Arthroplasty, Replacement, Knee Blood Coagulation Antithrombotic Agents Less << Phase 3 Completed - -
NCT01422304 - Completed - -
NCT03114969 - Completed - Netherlands ... More >> GSK Investigational Site Beek En Donk, Netherlands, 5741 CG GSK Investigational Site Beek, Netherlands, 6191JW GSK Investigational Site Eindhoven, Netherlands, 5623 EJ GSK Investigational Site Hengelo, Netherlands, 7555 DL GSK Investigational Site Hoorn, Netherlands, 1624 NP GSK Investigational Site Kloosterhaar, Netherlands, 7694 AC GSK Investigational Site Nijverdal, Netherlands, 7442 LS GSK Investigational Site Rotterdam, Netherlands, 3051 GV GSK Investigational Site Zutphen, Netherlands, 7207 AE United Kingdom GSK Investigational Site Northwood, Middlesex, United Kingdom, HA6 2RN GSK Investigational Site London, United Kingdom, EC1M 6BQ GSK Investigational Site London, United Kingdom, SW17 0QT GSK Investigational Site Sidcup, Kent, United Kingdom, DA14 6LT Less <<
NCT03357393 Sedation, Bronchoscopy Not Applicable Completed - -
NCT02996591 Nerve Block G... More >>eneral Anesthesia Spinal Anesthesia Pain Postoperative Nausea and Vomiting Less << Phase 4 Completed - United States, New York ... More >> Hospital for Special Surgery, New York New York, New York, United States, 10021 Less <<
NCT02410460 Rhytidoplasty Not Applicable Completed - United States, Missouri ... More >> Mercy Facial Plastic Surgery Center Springfield, Missouri, United States, 65804 Less <<
NCT00451100 Anesthesia, General Phase 3 Completed - -
NCT03346070 Neuromuscular Blockade Phase 4 Recruiting May 31, 2019 -
NCT00451217 Anesthesia, General Phase 3 Completed - -
NCT02197975 COPD Phase 1 Completed - United States, Maryland ... More >> SNBL Clinical Pharmacology Center Baltimore, Maryland, United States, 21201 Less <<
NCT02574611 Gastrointestinal Dysfunction Phase 1 Unknown December 2017 United States, New York ... More >> James J. Peters VA Medical Center Recruiting Bronx, New York, United States, 10468 Contact: Brian Lyons    718-584-9000 ext 3128    brian.lyons@va.gov    Contact: Joshua Hobson    718-584-9000 ext 3129    joshua.hobson@va.gov    Principal Investigator: Mark A. Korsten, MD          Sub-Investigator: William A. Bauman, MD          Sub-Investigator: Miroslav Radulovic, MD          Sub-Investigator: Marinella D. Galea, MD          Sub-Investigator: Ann M. Spungen, EdD Less <<
NCT02601508 Neuromuscular Blockade Not Applicable Unknown August 2017 Korea, Republic of ... More >> Chonnam University Hwasun Hospital Not yet recruiting Hwasun, Korea, Republic of, 519-763 Contact: Chanhong Park, BsC    +82-61-379-7598    cnuhpch@naver.com    Sub-Investigator: Seongheon Lee, MD, PhD          Sub-Investigator: Inje Kim, BsC          Sub-Investigator: Shi Young Chung, MD          Principal Investigator: Seongwook Jeong, MD, PhD Less <<
NCT03351608 Neuromuscular Blockade Phase 4 Recruiting September 24, 2020 United States, California ... More >> Childrens Hospital Los Angeles ( Site 0030) Recruiting Los Angeles, California, United States, 90027 Contact: Study Coordinator    323-361-8649       Lucille Packard Children's Hospital ( Site 0006) Completed Palo Alto, California, United States, 94304 United States, District of Columbia Children's National Medical Center ( Site 0008) Recruiting Washington, District of Columbia, United States, 20010 Contact: Study Coordinator    202-476-2025       United States, Michigan C.S. Mott Children's Hospital/ University of Michigan Medical center ( Site 0014) Recruiting Ann Arbor, Michigan, United States, 48109-4245 Contact: Study Coordinator    734-763-2435       United States, New Jersey Saint Peter's University Hospital [New Brunswick, NJ] ( Site 0009) Completed New Brunswick, New Jersey, United States, 08901 United States, North Carolina Duke University Medical Center ( Site 0019) Recruiting Durham, North Carolina, United States, 27710 Contact: Study Coordinator    919-681-4877       United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC ( Site 0005) Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Study Coordinator    412-692-6390 Less <<
NCT03513757 Headache Tumo... More >>r Seizure Disorder Neurofibromatoses Hydrocephalus Abdominal Neoplasm Spine Deformity Less << Phase 4 Recruiting December 31, 2018 United States, Wisconsin ... More >> Children's Hospital of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Susan P Taylor, MD, MPH    414-266-3560    sutaylor@mcw.edu    Contact: Amy Henry, MD    4142663560    ahenry@mcw.edu Less <<
NCT02861131 Postoperative Complications ... More >> Neuromuscular Blockade Less << Phase 4 Active, not recruiting December 31, 2018 United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT01706536 COPD Phase 2 Completed - -
NCT02347774 COPD Chronic ... More >>Obstructive Pulmonary Disease Less << Phase 3 Completed - -
NCT03574337 Residual Neuromuscular Blockad... More >>e Less << Phase 4 Not yet recruiting March 30, 2019 United States, Michigan ... More >> Henry Ford Health Systems Not yet recruiting Detroit, Michigan, United States, 48202 Contact: Mary Jarzebowski, MD    313-282-5673    mjarzeb1@hfhs.org Less <<
NCT02347761 COPD Phase 3 Completed - -
NCT02347774 - Completed - -
NCT01706536 - Completed - -
NCT02102542 - Completed - Thailand ... More >> Anesthesiology Department Siriraj Hospital Bangkoknoi, Bangkok, Thailand, 10700 Less <<
NCT02347761 - Completed - -
NCT02038829 COPD Phase 2 Completed - United States, Florida ... More >> Clinical Research of West Florida, Inc. Clearwater, Florida, United States, 33765 United States, North Carolina American Health Research, Inc. Charlotte, North Carolina, United States, 28207 North Carolina Clinical Research Raleigh, North Carolina, United States, 27607 United States, Oregon Clinical Research Institute of Southern Oregon, PC Medford, Oregon, United States, 97504 United States, South Carolina Palmetto Medical Research Associates, LLC Easley, South Carolina, United States, 29640 Greenville Pharmaceutical Research, Inc. Greenville, South Carolina, United States, 29615 Upstate Pharmaceutical Research Greenville, South Carolina, United States, 29615 S. Carolina Spartanburg, South Carolina, United States, 29303 Spartanburg Medical Research Spartanburg, South Carolina, United States, 29303 CU Pharmaceutical Research Union, South Carolina, United States, 29379 Less <<
NCT02038829 - Completed - -
NCT02953041 Asthma Phase 4 Completed - Canada, Saskatchewan ... More >> Asthma Research Lab, University of Saskatchewan Saskatoon, Saskatchewan, Canada, S7N 0W8 Less <<
NCT00745095 Spinal Cord Injury Phase 4 Completed - United States, New York ... More >> VA Medical Center, Bronx Bronx, New York, United States, 10468 Less <<
NCT03583021 Gallbladder Diseases Not Applicable Recruiting December 31, 2019 Korea, Republic of ... More >> Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine Recruiting Suwon, Seoul, Korea, Republic of Contact: Ji Eun Kim    82-31-219-5575 Less <<
NCT00745095 - Completed - -
NCT02189304 COPD Phase 1 Completed - United States, Maryland ... More >> SNBL Clinical Pharmacology Center Baltimore, Maryland, United States, 21201 Less <<
NCT02181023 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 4 Completed - Italy ... More >> Fondazione Salvatore Maugeri Milan, Italy, 20142 Less <<
NCT02403063 Respiratory Muscles ... More >> Electromyography Less << Phase 4 Completed - Belgium ... More >> OLV Hospital Aalst, Belgium, 9300 Less <<
NCT03346057 Reversal of Neuromuscular Bloc... More >>kade Less << Phase 4 Recruiting December 26, 2019 -
NCT02524145 Heart Failure Not Applicable Completed - United States, Texas ... More >> The Institute for Exercise and Environmental Medicine Dallas, Texas, United States, 75231 Less <<
NCT01285492 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - Japan ... More >> Novartis Investigative Site Anjo, Aichi, Japan, 446-8602 Novartis Investigative Site Nagoya, Aichi, Japan, 457-8511 Novartis Investigative Site Nishio-city, Aichi, Japan, 445-8510 Novartis Investigative Site Kasuga-city, Fukuoka, Japan, 816-0813 Novartis Investigative Site Kitakyushu, Fukuoka, Japan, 820-0052 Novartis Investigative Site Kurume, Fukuoka, Japan, 830-0011 Novartis Investigative Site Yanagawa, Fukuoka, Japan, 832-0059 Novartis Investigative Site Asahikawa, Hokkaido, Japan, 070-8644 Novartis Investigative Site Obihiro, Hokkaido, Japan, 080-0805 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Himeji-city, Hyogo, Japan, 672-8064 Novartis Investigative Site Kanazawa, Ishikawa, Japan, 920-8610 Novartis Investigative Site Takamatsu, Kagawa, Japan, 760-8538 Novartis Investigative Site Kawasaki, Kanagawa, Japan, 210-0852 Novartis Investigative Site Yokohama, Kanagawa, Japan, 236-0051 Novartis Investigative Site Koshi-city, Kumamoto, Japan, 861-1196 Novartis Investigative Site Matsusaka-city, Mie, Japan, 515-8544 Novartis Investigative Site Ueda, Nagano, Japan, 386-8610 Novartis Investigative Site Osaka-city, Osaka, Japan, 545-8586 Novartis Investigative Site Osakasayama, Osaka, Japan, 589-0022 Novartis Investigative Site Takatsuki, Osaka, Japan, 569-1192 Novartis Investigative Site Toyonaka, Osaka, Japan, 560-8552 Novartis Investigative Site Kawaguhi-city, Saitama, Japan, 333-0833 Novartis Investigative Site Hamamatsu, Shizuoka, Japan, 430-8525 Novartis Investigative Site Fuchu, Tokyo, Japan, 183-8524 Novartis Investigative Site Meguro, Tokyo, Japan, 152-8902 Novartis Investigative Site Yamagata city, Yamagata, Japan, 990-8533 Novartis Investigative Site Ube, Yamaguchi, Japan, 755-0241 Novartis Investigative Site Akita, Japan, 010-0933 Novartis Investigative Site Fukuoka, Japan, 811-0213 Novartis Investigative Site Fukuoka, Japan, 812-0033 Novartis Investigative Site Fukuoka, Japan, 815-8588 Novartis Investigative Site Kochi, Japan, 780-8077 Novartis Investigative Site Osaka, Japan, 558-8558 Novartis Investigative Site Wakayama, Japan, 641-8510 Less <<
NCT01285492 - Completed - -
NCT01120717 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT03324607 Copd Phase 2 Phase 3 Recruiting March 2019 United States, North Carolina ... More >> Duke Asthma, Allergy, and Airway Center Recruiting Durham, North Carolina, United States, 27705 Contact: Erika Coleman    919-479-0861 Less <<
NCT02284412 Respiratory-Gated Imaging Tech... More >>niques Less << Phase 4 Completed - Belgium ... More >> OLV Hospital Aalst, Belgium, 9300 Less <<
NCT03111121 Microlaryngoscopy ... More >> Rigid Bronchoscopy Less << Phase 4 Recruiting December 31, 2018 United States, West Virginia ... More >> WVU Healthcare Ruby Memorial Hospital Recruiting Morgantown, West Virginia, United States, 26506 Contact: Pavithra Ranganathan, MD    304-598-4929    ranganathanp@wvuhealthcare.com    Contact: Matthew Ellison, MD    304-598-4929    EllisonMa@wvuhealthcare.com    Principal Investigator: Pavithra Ranganathan, MD          Sub-Investigator: Matthew Ellison, MD Less <<
NCT01768780 Orthopedic Surgery-lower Leg S... More >>urgery Less << Not Applicable Unknown November 2014 Korea, Republic of ... More >> Severance hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01120717 - Completed - -
NCT01854658 - Completed - -
NCT03742141 Vocal Cord Function in Neck Pr... More >>ocedures Less << Not Applicable Recruiting September 26, 2020 United States, New York ... More >> Mount Sinai Queens Not yet recruiting Long Island City, New York, United States, 11102 Mount Sinai Beth Israel Recruiting New York, New York, United States, 10003 Mount Sinai West Recruiting New York, New York, United States, 10019 Mount Sinai St. Luke's Recruiting New York, New York, United States, 10025 The Mount Sinai Hospital Recruiting New York, New York, United States, 10029 Less <<
NCT01142648 Anaesthesia Phase 4 Completed - Finland ... More >> Tampere University Hospital Tampere, Finland Less <<
NCT01587079 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - United States, Arizona ... More >> Pearl Investigative Site Glendale, Arizona, United States United States, California Pearl Investigative Site Rancho Mirage, California, United States United States, Connecticut Pearl Investigative Site Waterbury, Connecticut, United States United States, Florida Pearl Investigative Site Clearwater, Florida, United States, 33765 Pearl Investigative Site Clearwater, Florida, United States Pearl Investigative Site Pensacola, Florida, United States Pearl Investigative Site Winter Park, Florida, United States, 32789 United States, Louisiana Pearl Investigative Site Lafayette, Louisiana, United States United States, Massachusetts Pearl Investigative Site North Dartmouth, Massachusetts, United States United States, Minnesota Pearl Investigative Site Fridley, Minnesota, United States United States, Missouri Pearl Investigative Site St. Louis, Missouri, United States United States, New Jersey Pearl Investigative Site Summit, New Jersey, United States United States, Ohio Pearl Investigative Site Cincinnati, Ohio, United States United States, Oregon Pearl Investigative Site Medford, Oregon, United States, 97504 Pearl Investigative Site Medford, Oregon, United States United States, South Carolina Pearl Investigative Site Rock Hill, South Carolina, United States Pearl Investigative Site Spartanburg, South Carolina, United States, 29303 United States, Texas Pearl Investigative Site San Antonio, Texas, United States United States, West Virginia Pearl Investigative Site Morgantown, West Virginia, United States Less <<
NCT02370433 Spinal Cord Injury ... More >> Neurogenic Bowel Less << Phase 1 Recruiting December 2018 United States, New York ... More >> James J. Peters VA Medical Center Recruiting The Bronx, New York, United States, 10468 Contact: Brian Lyons    718-584-9000 ext 3128    brian.lyons@va.gov    Contact: Joshua Hobson    718-584-9000 ext 3129    joshua.hobson@va.gov    Principal Investigator: Mark A. Korsten, MD          Sub-Investigator: William A. Bauman, MD          Sub-Investigator: Miroslav Radulovic, MD          Sub-Investigator: Marinella D. Galea, MD          Sub-Investigator: Ann M. Spungen, EdD          Sub-Investigator: Gregory Schilero, MD Less <<
NCT03513406 Burns Phase 3 Active, not recruiting March 2021 United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT01748643 Obesity Lapar... More >>oscopic Gastric Bypass Surgery Surgical Conditions Respiratory Function Cerebral Tissue Oxygenation Less << Phase 4 Completed - Belgium ... More >> Ziekenhuis Oost-Limburg Genk, Limburg, Belgium, 3600 Less <<
NCT01748643 - Completed - -
NCT03250182 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 1 Completed - United States, Florida ... More >> Pearl Investigative Site Clearwater, Florida, United States, 33765 Less <<
NCT01854658 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT03138967 Malignant Neoplasms of Urinary... More >> Tract Bladder Cancer Less << Phase 4 Recruiting September 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       CR_Study_Registration@mdanderson.org Less <<
NCT01199237 - Completed - -
NCT03432845 - Not yet recruiting March 2019 -
NCT00855283 SCI Phase 2 Completed - United States, New York ... More >> VA Medical Center, Bronx Bronx, New York, United States, 10468 Less <<
NCT01453530 Anesthesia Recovery Period Phase 4 Unknown September 2012 Netherlands ... More >> UMC Sint Radboud Recruiting Nijmegen, Gelderland, Netherlands, 6500 HB Contact: Diana M Peters-Gómez Valdez, MD       d.peters-gomezvaldez@anes.umcn.nl    Principal Investigator: Gert J. Scheffer, MD PhD          Sub-Investigator: Diana M. Peters-Gómez Valdez, MD Less <<
NCT01199237 Airway Reflexes, Protective ... More >> Recovery After Neuromuscular Block Anesthetic Recovery Less << Phase 4 Completed - United States, California ... More >> UCSF Helen Diller Cancer Center San Francisco, California, United States, 94115 UCSF Moffitt-Long Hospital San Francisco, California, United States, 94143 Less <<
NCT00570778 - Completed - -
NCT02825576 Pulmonary Complications Phase 4 Not yet recruiting July 2020 -
NCT00570778 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 2 Completed - United States, Missouri ... More >> Novartis Investigator Site Saint Louis, Missouri, United States United States, North Carolina Novartis Investigator Site Charlotte, North Carolina, United States Novartis Investigator site Raleigh, North Carolina, United States Belgium Novartis Investigator Site Antwerpen, Belgium Novartis Investigator Site Gent, Belgium Novartis Investigator Site Jambes, Belgium Novartis Investigator Site Saint Vith, Belgium Canada Novartis Investigator Site Moncton, Canada Novartis Investigator Site Montreal, Canada Novartis Investigator site Toronto, Canada Germany Novartis Investigator Site Bad Worishofen, Germany Novartis Investigator Site Berlin, Germany Novartis Investigator Site Frankfurt, Germany Novartis Investigator Site Mainz, Germany Novartis Investigator Site Rudersdorf, Germany Novartis Investigator Site Wiesbaden, Germany Netherlands Novartis Investigator Site Almelo, Netherlands Novartis Investigator Site Breda, Netherlands Novartis Investigator site Eindhoven, Netherlands Novartis investigator site Heerlen, Netherlands Novartis Investigator Site Nijmegen, Netherlands Novartis Investigator Site Veldhoven, Netherlands Less <<
NCT02430272 Fever COMPLETED 2025-12-14 Ilsan Paik hospital, Goyang-si... More >>, Gyeonggi-do, 411-706, Korea, Republic of Less <<
NCT03168308 Neuromuscular Blockade Phase 4 Recruiting June 30, 2019 United States, Texas ... More >> Parkland Health & Hospital System Recruiting Dallas, Texas, United States, 75211 Contact: Tiffany S. Moon, MD Less <<
NCT00558285 - Completed - -
NCT02860507 Neuromuscular Blockade Phase 4 Enrolling by invitation February 2018 -
NCT00558285 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 2 Completed - -
NCT01587079 - Completed - -
NCT01176903 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 1 Phase 2 Completed - United Kingdom ... More >> Medicines Evaluation Unit Manchester, United Kingdom, M23 9QZ Less <<
NCT02867761 COPD (Chronic Obstructive Pulm... More >>onary Disease) Less << Phase 3 Recruiting July 2019 United States, Alabama ... More >> Universityof Alabama Recruiting Birmingham, Alabama, United States, 35294 Contact: Erica Anderson       eanderson@uabmc.edu    Principal Investigator: Mark Dransfield          United States, California University of California Recruiting Los Angeles, California, United States, 90095 Contact: Miguel Villarreal       MiguelVillarreal@mednet.ucla.edu    Principal Investigator: Igor Barjaktarevic, MD, PhD          University of California Recruiting San Francisco, California, United States, 94143 Contact: Sundos Yassin       sundos.yassin@ucsf.edu    Principal Investigator: Stephen Lazarus, MD          LABIOMED at Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90502 Contact: Carmen Lopez-Garcia       Clopez_garcia@labiomed.org    Principal Investigator: William Stringer, MD          United States, Illinois University of Illinois Recruiting Chicago, Illinois, United States, 60608 Contact: Lauren Castro       lschra3@uic.edu    Principal Investigator: Jerry Krishnan, MD, PhD          Northwestern University Recruiting Chicago, Illinois, United States, 60657 Contact: Jenny Hixon       j-franzen@northwestern.edu    Principal Investigator: Ravi Kalhan          United States, Iowa University of Iowa Recruiting Iowa City, Iowa, United States, 52242 Contact: Fozia Ghaforr       fozia-ghafoor@uiowa.edu    Principal Investigator: Alejandro Comellas          United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21224 Contact: Cheryl Clare       cdaniel9@jhu.edu    Principal Investigator: Bob Wise          United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Crystal Cutlip       ccutlip@umich.edu    Principal Investigator: MeiLan Han          United States, Minnesota Minneapolis VA Medical Center Recruiting Minneapolis, Minnesota, United States, 55417 Contact: Allison Aase       Allison.Aase@va.gov    Principal Investigator: Chris Wendt, MD          Minnesota Health partners Recruiting Saint Paul, Minnesota, United States, 55130 Contact: Pamela Neuenfeldt, MPH       pamela.j.neuenfeldt@healthpartners.com    Principal Investigator: Charlene McEvoy          United States, New York Cornell University Recruiting New York, New York, United States, 10021 Contact: Matthew Marcelino       mam2225@med.cornell.edu    Principal Investigator: Robert kaner, MD          United States, North Carolina Duke University Recruiting Durham, North Carolina, United States, 27705 Contact: Erika Coleman       erika.coleman@duke.edu    Principal Investigator: Neil MacIntyre          United States, Pennsylvania Temple University Recruiting Philadelphia, Pennsylvania, United States, 19140 Contact: Dee Fehrle       Delores.Fehrle@tuhs.temple.edu    Principal Investigator: Gerard Criner, MD          University of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Elizabeth Stempkowski       stempkowskiem@upmc.edu    Principal Investigator: Toru Nyunoya, MD          United States, Texas Baylor College of Medicine Recruiting Houston, Texas, United States, 77505 Contact: Brock Melissa       mbrock@bcm.edu    Principal Investigator: Nicola Hanania, MD, MS          United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84132 Contact: Newsha Sedghi       u0984618@utah.edu    Principal Investigator: Kanner Richard Less <<
NCT02119234 COPD Phase 1 Completed - Poland ... More >> Medical University in Lodz Lodz, ul. Kopcińskiego 22, Poland, 90-153 Less <<
NCT02370862 Spinal Cord Injury ... More >> Neurogenic Bowel Less << Early Phase 1 Completed - United States, New York ... More >> James J. Peters VA Medical Center Bronx, New York, United States, 10468 Less <<
NCT03322657 Neuromuscular Blockade ... More >> Anesthesia Less << Phase 4 Recruiting October 30, 2019 United States, Ohio ... More >> Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Ehab Farag, MD    216-444-7550    farage@ccf.org    Contact: Roberta J Johnson    216-444-9950    johnsor13@ccf.org Less <<
NCT01479764 - Completed - -
NCT02296411 Asthma Phase 2 Completed - Bulgaria ... More >> Chiesi Clinical Trial Site 0107 Ruse, Bulgaria, 7002 Chiesi Clinical Trial Site 0106 Sevlievo, Bulgaria, 5400 Chiesi Clinical Trial Site 0101 Sofia, Bulgaria, 1000 Chiesi Clinical Trial Site 0109 Sofia, Bulgaria, 1336 Chiesi Clinical Trial Site 0108 Sofia, Bulgaria, 1407 Chiesi Clinical Trial Site 0102 Sofia, Bulgaria, 1431 Chiesi Clinical Trial Site 0103 Sofia, Bulgaria, 1431 Germany Chiesi Clinical Trial Site 0201 Berlin, Germany, D-12165 Chiesi Clinical Trial Site 0203 Leipzig, Germany, 04207 Chiesi Clinical Trial Site 0202 Leipzig, Germany, 04357 Chiesi Clinical Trial Site 0206 Magdeburg, Germany, 39112 Chiesi Clinical Trial Site 0207 Radebeul, Germany, 01445 Chiesi Clinical Trial Site 0208 Witten, Germany, 58452 Italy Chiesi Clinical Trial Site 0306 Brescia, Italy, 25123 Chiesi Clinical Trial Site 0301 Pisa, Italy, 56124 Chiesi Clinical Trial Site 0304 Pisa, Italy, 56124 Chiesi Clinical Trial Site 0303 Pordenone, Italy, 33170 Netherlands Chiesi Clinical Trial Site 0404 Assen, Netherlands, 9401 RK Chiesi Clinical Trial Site 0405 Helmond, Netherlands, 5707 HA Poland Chiesi Clinical Trial Site 0501 Bialystok, Poland, 15-010 Chiesi Clinical Trial Site 0502 Bialystok, Poland, 15-351 Chiesi Clinical Trial Site 0503 Elblag, Poland, 82-300 Chiesi Clinical Trial Site 0507 Krakow, Poland, 30-349 Chiesi Clinical Trial Site 0504 Krakow, Poland, 31-011 Chiesi Clinical Trial Site 0512 Lodz, Poland, 90-141 Chiesi Clinical Trial Site 0510 Lodz, Poland, 90-252 Chiesi Clinical Trial Site 0505 Wroclaw, Poland, 53-310 Chiesi Clinical Trial Site 0506 Zgierz, Poland, 95-100 Less <<
NCT02127866 Asthma Phase 2 Completed - -
NCT01479764 Surgical Procedures, Elective Phase 3 Completed - -
NCT02276222 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT02276222 - Completed - -
NCT02948582 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - -
NCT02375217 Anesthesia Recovery Phase 4 Completed - Lebanon ... More >> AUBMC Beirut, Lebanon Less <<
NCT02948582 - Completed - -
NCT03229486 Emergence Delirium Phase 4 Recruiting April 30, 2019 Korea, Republic of ... More >> Pusan National University Yangsan Hospital Recruiting Yangsan, Gyeongsangnam-do, Korea, Republic of, 50612 Contact: Juyeon Park, MD Less <<
NCT03116997 Surgery Phase 3 Recruiting April 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: German Echeverry, MD    212-639-8865       United States, New York Memorial Sloan Kettering Cancer Center @ Commack Recruiting Commack, New York, United States, 11725 Contact: German Echeverry, MD    212-639-8865       Memoral Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: German Echeverry, MD    212-639-8865       Memorial Sloan - Kettering Cancer Center Recruiting New York, New York, United States, 10021 Contact: German Echeverry, MD    212-639-8865 Less <<
NCT02040597 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 1 Completed - Poland ... More >> Biovirtus Research Site Nadarzyn, Mokra 7, Poland, 05-830 Medical University in Lodz Lodz, ul. Kopcińskiego 22, Poland, 90-153 Less <<
NCT01176851 Healthy Phase 1 Completed - United Kingdom ... More >> Medicines Evaluation Unit Manchester, United Kingdom, M23 9QZ Less <<
NCT01911364 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - Germany ... More >> Institut für klinische Forschung Hessen, Germany Hungary Csongrád Megyei Mellkasi Betegségek Szakkórháza Szeged, Hungary Italy Azienda Ospedaliera Perugia Perugia, Italy Less <<
NCT02613494 Sialorrhea Phase 1 Phase 2 Completed - United Kingdom ... More >> Lancashire Care NHS Foundation Trust Preston, Lancashire, United Kingdom Mersey Care NHS Trust Liverpool, Merseyside, United Kingdom Less <<
NCT01398111 COPD Phase 1 Completed - Belgium ... More >> Clinical Pharmacology Unit - SGS Life Science Services Antwerpen, Lange Beeldekensstraat 267, Belgium, 2060 Less <<
NCT01476813 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - United Kingdom ... More >> Medicines Evaluation Unit Ltd. Manchester, United Kingdom Less <<
NCT02951312 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - -
NCT00315536 Urological Surgery Phase 2 Completed - Belgium ... More >> University Hospital Ghent Ghent, Belgium, 9000 Less <<
NCT00491894 - Completed - -
NCT02129660 Hyperhidrosis Phase 2 Completed - United States, California ... More >> California Dermatology & Clinical Research Institute Encinitas, California, United States, 92024 Center For Dermatology Clinical Research Fremont, California, United States, 94538 United States, Florida Olympian Clinical Research Tampa, Florida, United States, 33609 Kenneth R. Beer MD West Palm Beach, Florida, United States, 33401 United States, Indiana Shideler Clinical Research Center Carmel, Indiana, United States, 46032 United States, Missouri Saint Louis University Dermatology Saint Louis, Missouri, United States, 63122 United States, Ohio Haber Dermatology and Cosmetic Surgery Beachwood, Ohio, United States, 44122 United States, Tennessee Rivergate Dermatology Clinical Research Center, PLLC Goodlettsville, Tennessee, United States, 37072 United States, Texas DermResearch, Inc Austin, Texas, United States, 78759 United States, Utah Dermatology Research Center, Inc. Salt Lake City, Utah, United States, 84117 United States, Virginia Virginia Clinical Research, Inc. Norfolk, Virginia, United States, 23507 United States, Washington Dermatology Associates Seattle, Washington, United States, 98101 Women's Clinical Research Center Seattle, Washington, United States, 98105 Premier Clinical Research Spokane, Washington, United States, 99204 Canada Innovaderm Research Inc. Montreal, Canada, H2K 4L5 Less <<
NCT00491894 Cerebral Palsy ... More >> Neurological Conditions Mental Retardation Sialorrhea Less << Phase 3 Completed - United States, Colorado ... More >> Rocky Mountain Pediatrics Lakewood, Colorado, United States, 80214 United States, Georgia Child Neurology Associates, PC Atlanta, Georgia, United States, 30342 United States, New York St. Mary's for Children Bayside, New York, United States, 11360 United States, Ohio Akron's Childrens Akron, Ohio, United States, 44308 Hattie Larltham Center for Children with Disabilities Mantua, Ohio, United States, 44255 United States, Oklahoma The Children's Center Bethany, Oklahoma, United States, 73008 United States, Texas Alamo City Clinical Research San Antonio, Texas, United States, 78258 Less <<
NCT02189577 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - Bulgaria ... More >> Chiesi Clinical Trial Site 1017 Sevlievo, Bulgaria Chiesi Clinical Trial Site 1010 Sofia, Bulgaria Chiesi Clinical Trial Site 1011 Sofia, Bulgaria Chiesi Clinical Trial Site 1014 Sofia, Bulgaria Chiesi Clinical Trial Site 1015 Sofia, Bulgaria Chiesi Clinical Trial Site 1016 Sofia, Bulgaria Chiesi Clinical Trial Site 1012 Stara Zagora, Bulgaria Chiesi Clinical Trial Site 1013 Troyan, Bulgaria Germany Chiesi Clinical Trial Site 2024 Berlin, Germany Chiesi Clinical Trial Site 2028 Berlin, Germany Site 2020 - Pulmonary Research Institute at Hospital Grosshansdorf Großhansdorf, Germany, D-22927 Chiesi Clinical Trial Site 2027 Hamburg, Germany Chiesi Clinical Trial Site 2026 Leipzig, Germany Chiesi Clinical Trial Site 2023 Magdeburg, Germany Chiesi Clinical Trial Site 2021 Radebeul, Germany Chiesi Clinical Trial Site 2022 Witten, Germany Poland Chiesi Clinical Trial Site 3039 Bydgoszcz, Poland Chiesi Clinical Trial Site 3032 Katowice, Poland Chiesi Clinical Trial Site 3035 Kraków, Poland Chiesi Clinical Trial Site 3037 Lubin, Poland Chiesi Clinical Trial Site 3031 Ostrowiec Świętokrzyski, Poland Chiesi Clinical Trial Site 3033 Oświęcim, Poland Chiesi Clinical Trial Site 3038 Rzeszów, Poland Chiesi Clinical Trial Site 3034 Tarnów, Poland Chiesi Clinical Trial Site 3030 Wrocław, Poland Chiesi Clinical Trial Site 3036 Zgierz, Poland United Kingdom Site 4040 - Royal Brompton and Harefield NHS Foundation Trust; South Kensington Campus London, United Kingdom, SW7 2AZ Chiesi Clinical Trial Site 4042 London, United Kingdom Chiesi Clinical Trial Site 4041 Manchester, United Kingdom Less <<
NCT01917331 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - Hungary ... More >> Dr Beatrix BALINT Szeged, Hungary, 6722 Less <<
NCT02512302 COPD Phase 1 Completed - United Kingdom ... More >> Queen Anne Street Medical Center London, United Kingdom, W1G 8HU Medicines evaluation Unit Ltd. Manchester, United Kingdom, M23 9QZ Less <<
NCT02512302 - Completed - -
NCT01191398 Sialorrhea Not Applicable Completed - United States, Texas ... More >> Children's Medical Center at Dallas Dallas, Texas, United States, 75390 Less <<
NCT01191398 - Completed - -
NCT02382198 Sialorrhea Pa... More >>rkinson's Disease Less << Phase 2 Recruiting December 2018 Canada, Ontario ... More >> The Ottawa Hospital - Civic Campus Recruiting Ottawa, Ontario, Canada, K1Y 4E9 Contact: Shawna Reddie    613-798-5555 ext 19369    sreddie@ohri.ca    Contact: Tiago Mestre, MSc, MD    613-798-5555 ext 18986    tmestre@toh.ca    Principal Investigator: Tiago Mestre, MSc, MD          Toronto Western Hospital Recruiting Toronto, Ontario, Canada, M5T 2S8 Contact: Alison Tian    416-603-5800 ext 3415    Alison.Tian@uhnresearch.ca    Contact: Susan Fox, MBChB, MRCP, PhD    416-699-9837    Sfox@uhnresearch.ca    Principal Investigator: Susan Fox, MBChB, MRCP, PhD Less <<
NCT02129660 - Completed - -
NCT02951312 - Completed - -
NCT02872935 Nausea Vomiti... More >>ng Less << Phase 4 Recruiting December 31, 2018 United States, Iowa ... More >> University of Iowa Recruiting Iowa City, Iowa, United States, 52242 Contact: Kokila N Thenuwara, MD    319-541-8634    kokila-thenuwara@uiowa.edu    Principal Investigator: Kokila N Thenuwara, MD Less <<
NCT02016885 Hyperhidrosis Phase 2 Completed - United States, Arkansas ... More >> Burke Pharmaceutical Research Hot Springs, Arkansas, United States, 71913 Gary M. Petrus, MD, PA Little Rock, Arkansas, United States, 72202 United States, California California Dermatology & Clinical Research Institute Encinitas, California, United States, 92024 Center For Dermatology Clinical Research Fremont, California, United States, 94538 United States, Florida Florida Academic Dermatology Center Miami, Florida, United States, 33136 Kenneth R. Beer, MD, PA West Palm Beach, Florida, United States, 33401 United States, Indiana Shideler Clinical Research Center Carmel, Indiana, United States, 46032 United States, Kansas Cypress Medical Research Center, LLC Wichita, Kansas, United States, 67226 United States, Minnesota Minnesota Clinical Study Center Fridley, Minnesota, United States, 55432 United States, Missouri Saint Louis University Dermatology Saint Louis, Missouri, United States, 63122 United States, Nebraska Skin Specialists, PC Omaha, Nebraska, United States, 68144 United States, New Jersey The Dermatology Group, PC Verona, New Jersey, United States, 07044 United States, Oregon Oregon Medical Research Center Portland, Oregon, United States, 97223 United States, Texas J&S Studies, Inc. College Station, Texas, United States, 77845 Clinical Trials of Texas, Inc. San Antonio, Texas, United States, 78229 United States, Utah Dermatology Research Center, Inc. Salt Lake City, Utah, United States, 84117 United States, Virginia Virginia Clinical Research, Inc. Norfolk, Virginia, United States, 23507 Westend Dermatology Associates Richmond, Virginia, United States, 23233 United States, Washington Dermatology Associates Seattle, Washington, United States, 98101 Women's Clinical Research Center Seattle, Washington, United States, 98105 Premier Clinical Research Spokane, Washington, United States, 99204 Less <<
NCT03081156 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 4 Recruiting December 31, 2019 United States, California ... More >> Los Angeles Biomedical Institute, Inc (LABIOMED) Recruiting Torrance, California, United States, 90509 Contact: William Stringer, MD    424-571-7626    wstringer@labiomed.org    Contact: Leticia Diaz, RN    310-222-8022 ext 7258    ldiaz@labiomed.org    Principal Investigator: William W Stringer, MD Less <<
NCT02016885 - Completed - -
NCT03580889 Lower Extremity Fracture Phase 4 Recruiting September 2018 Nepal ... More >> Dr. BishnuPokharel Recruiting Dharān Bāzār, Sunsari, Nepal, 977 Contact: Bishnu Pokharel, Dr.    025525555    Bpkihs@bpkihs.edu    Principal Investigator: Raju Thapamagar, Dr Less <<
NCT03322098 Spinal Anesthesia Not Applicable Completed - Korea, Republic of ... More >> Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine Seoul, Korea, Republic of, 03722 Less <<
NCT01588717 Hyperhydrosis|Depression PHASE1 TERMINATED 2025-06-16 Thomas Jefferson University, P... More >>hiladelphia, Pennsylvania, 19107, United States Less <<
NCT03050242 Cholecystitis, Acute COMPLETED 2017-05-19 Kangbuk Samsung Hospital, Seou... More >>l, 03181, Korea, Republic of Less <<
NCT03322150 Spinal Anesthesia Not Applicable Recruiting October 2018 Korea, Republic of ... More >> Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 03722 Contact: Ki-Young Lee, MD Less <<
NCT02228473 Catheter Site Discomfort ... More >> Complications Anesthesia Urinary Bladder Neoplasms Less << Not Applicable Unknown March 2015 Korea, Republic of ... More >> Seoul National University of Hospital Recruiting Seoul, Korea, Republic of, Korea, Republic of Contact: Hee-Pyoung Park, PhD    +82-10-2971-7647    hppark@snu.ac.kr    Principal Investigator: Hyun-Chang Kim, MD          Principal Investigator: Hee-Pyoung Park, PhD Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.51mL

0.50mL

0.25mL

12.55mL

2.51mL

1.26mL

25.10mL

5.02mL

2.51mL

References

 

Historical Records

Categories